The clinical utility of tuberculin skin test and interferon-γ release assay in the diagnosis of active tuberculosis among young adults: A prospective observational study

BMC Infectious Diseases

Volumn 11, Issue , 2011, Pages

  Lee, Ji Eun ^a   Kim, Hee Jin ^b   Lee, Sei Won ^a,c  

^a Armed Forces Capital Hospital   (South Korea)

^b Korean Institute of Tuberculosis   (South Korea)

^c Seoul National University Bundang Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; EMPYEMA; FEMALE; HUMAN; INTERFERON GAMMA RELEASE ASSAY; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PARAGONIMIASIS; PNEUMONIA; PREDICTIVE VALUE; PROSPECTIVE STUDY; PUBLIC HOSPITAL; SENSITIVITY AND SPECIFICITY; SOUTH KOREA; TUBERCULIN TEST; TUBERCULOSIS; TUBERCULOUS LYMPHADENITIS; TUBERCULOUS PLEURISY; COMPARATIVE STUDY; DIAGNOSIS, MEASUREMENT AND ANALYSIS; EVALUATION; IMMUNOLOGY; METHODOLOGY; MONONUCLEAR CELL; SECRETION; SKIN TEST; SOLDIER;

INTERFERON;

ADULT; CLINICAL LABORATORY TECHNIQUES; HUMANS; INTERFERONS; LEUKOCYTES, MONONUCLEAR; MALE; MILITARY PERSONNEL; PROSPECTIVE STUDIES; REPUBLIC OF KOREA; SENSITIVITY AND SPECIFICITY; SKIN TESTS; TUBERCULIN TEST; TUBERCULOSIS; YOUNG ADULT;

EID: 79955124167     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-11-96     Document Type: Article

References (30)

1. World Health Organization(WHO) report 2009 Global tuberculosis control. Accessed 1 Feb 2010., World Health Organization(WHO) report 2009., http://www.who.int/tb/publications/global_report/2009/key_points/en/
2. World Health Organization(WHO) Global TB database. Accessed 1 Feb 2010, World Health Organization(WHO)., http://apps.who.int/globalatlas/predefinedreports/tb/index.asp?strSelectedCountry=KOR
3. Diagnostic Standards and Classification of Tuberculosis in Adults and Children. This official statement of the American Thoracic Society and the Centers for Disease Control and Prevention was adopted by the ATS Board of Directors, July 1999. This statement was endorsed by the Council of the Infectious Disease Society of America, September 1999. Am J Respir Crit Care Med 2000, 161(4 Pt 1):1376-1395.
4. Laszlo A, Gill P, Handzel V, Hodgkin MM, Helbecque DM. Conventional and radiometric drug susceptibility testing of Mycobacterium tuberculosis complex. J Clin Microbiol 1983, 18(6):1335-1339. 272903, 6418755.
5. Frieden TR, Sterling TR, Munsiff SS, Watt CJ, Dye C. Tuberculosis. Lancet 2003, 362(9387):887-899. 10.1016/S0140-6736(03)14333-4, 13678977.
6. Rapid diagnostic tests for tuberculosis: what is the appropriate use? American Thoracic Society Workshop. Am J Respir Crit Care Med 1997, 155(5):1804-1814.
7. Kang YA, Lee HW, Hwang SS, Um SW, Han SK, Shim YS, Yim JJ. Usefulness of whole-blood interferon-gamma assay and interferon-gamma enzyme-linked immunospot assay in the diagnosis of active pulmonary tuberculosis. Chest 2007, 132(3):959-965. 10.1378/chest.06-2805, 17505029.
8. Kobashi Y, Mouri K, Yagi S, Obase Y, Miyashita N, Okimoto N, Matsushima T, Kageoka T, Oka M. Clinical utility of the QuantiFERON TB-2G test for elderly patients with active tuberculosis. Chest 2008, 133(5):1196-1202. 10.1378/chest.07-1995, 18263689.
9. Park SY, Jeon K, Um SW, Kwon OJ, Kang ES, Koh WJ. Clinical utility of the QuantiFERON-TB Gold In-Tube test for the diagnosis of active pulmonary tuberculosis. Scand J Infect Dis 2009, 41(11-12):818-822. 10.3109/00365540903214298, 19922063.
10. Sester M, Sotgiu G, Lange C, Giehl C, Girardi E, Migliori GB, Bossink A, Dheda K, Diel R, Dominguez J, et al. Interferon-{gamma} release assays for the diagnosis of active tuberculosis: A systematic review and meta-analysis. Eur Respir J
11. Bianchi L, Galli L, Moriondo M, Veneruso G, Becciolini L, Azzari C, Chiappini E, de Martino M. Interferon-gamma release assay improves the diagnosis of tuberculosis in children. Pediatr Infect Dis J 2009, 28(6):510-514. 10.1097/INF.0b013e31819abf6b, 19504735.
12. Baba K, Sornes S, Hoosen AA, Lekabe JM, Mpe MJ, Langeland N, Dyrhol-Riise AM. Evaluation of immune responses in HIV infected patients with pleural tuberculosis by the QuantiFERON TB-Gold interferon-gamma assay. BMC Infect Dis 2008, 8:35. 10.1186/1471-2334-8-35, 2279134, 18366633.
13. Diel R, Loddenkemper R, Meywald-Walter K, Gottschalk R, Nienhaus A. Comparative performance of tuberculin skin test, QuantiFERON-TB-Gold In Tube assay, and T-Spot.TB test in contact investigations for tuberculosis. Chest 2009, 135(4):1010-1018. 10.1378/chest.08-2048, 19017873.
14. Pai M, Zwerling A, Menzies D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med 2008, 149(3):177-184. 2951987, 18593687.
15. Farhat M, Greenaway C, Pai M, Menzies D. False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria?. Int J Tuberc Lung Dis 2006, 10(11):1192-1204.
16. Mazurek GH, Jereb J, Lobue P, Iademarco MF, Metchock B, Vernon A. Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR Recomm Rep 2005, 54(RR-15):49-55.
17. Im JG, Itoh H, Lee KS, Han MC. CT-pathology correlation of pulmonary tuberculosis. Crit Rev Diagn Imaging 1995, 36(3):227-285.
18. Im JG, Itoh H, Shim YS, Lee JH, Ahn J, Han MC, Noma S. Pulmonary tuberculosis: CT findings--early active disease and sequential change with antituberculous therapy. Radiology 1993, 186(3):653-660.
19. Im JG, Webb WR, Han MC, Park JH. Apical opacity associated with pulmonary tuberculosis: high-resolution CT findings. Radiology 1991, 178(3):727-731.
20. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977, 33(1):159-174. 10.2307/2529310, 843571.
21. Kang YA, Lee HW, Yoon HI, Cho B, Han SK, Shim YS, Yim JJ. Discrepancy between the tuberculin skin test and the whole-blood interferon gamma assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country. JAMA 2005, 293(22):2756-2761. 10.1001/jama.293.22.2756, 15941805.
22. Ildirim I, Hacimustafaoglu M, Ediz B. Correlation of tuberculin induration with the number of Bacillus Calmette-Guerin vaccines. Pediatr Infect Dis J 1995, 14(12):1060-1063. 10.1097/00006454-199512000-00006, 8745018.
23. Sepulveda RL, Heiba IM, King A, Gonzalez B, Elston RC, Sorensen RU. Evaluation of tuberculin reactivity in BCG-immunized siblings. Am J Respir Crit Care Med 1994, 149(3 Pt 1):620-624.
24. Rodrigues LC, Pereira SM, Cunha SS, Genser B, Ichihara MY, de Brito SC, Hijjar MA, Dourado I, Cruz AA, Sant'Anna C, et al. Effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: the BCG-REVAC cluster-randomised trial. Lancet 2005, 366(9493):1290-1295. 10.1016/S0140-6736(05)67145-0, 16214599.
25. Raby E, Moyo M, Devendra A, Banda J, De Haas P, Ayles H, Godfrey-Faussett P. The effects of HIV on the sensitivity of a whole blood IFN-gamma release assay in Zambian adults with active tuberculosis. PLoS One 2008, 3(6):e2489. 10.1371/journal.pone.0002489, 2409073, 18560573.
26. Lee SS, Chou KJ, Su IJ, Chen YS, Fang HC, Huang TS, Tsai HC, Wann SR, Lin HH, Liu YC. High prevalence of latent tuberculosis infection in patients in end-stage renal disease on hemodialysis: Comparison of QuantiFERON-TB GOLD, ELISPOT, and tuberculin skin test. Infection 2009, 37(2):96-102. 10.1007/s15010-008-8082-3, 19139810.
27. Mori T, Sakatani M, Yamagishi F, Takashima T, Kawabe Y, Nagao K, Shigeto E, Harada N, Mitarai S, Okada M, et al. Specific detection of tuberculosis infection: an interferon-gamma-based assay using new antigens. Am J Respir Crit Care Med 2004, 170(1):59-64. 10.1164/rccm.200402-179OC, 15059788.
28. Kobashi Y, Mouri K, Obase Y, Fukuda M, Miyashita N, Oka M. Clinical evaluation of QuantiFERON TB-2G test for immunocompromised patients. Eur Respir J 2007, 30(5):945-950. 10.1183/09031936.00040007, 17652312.
29. Targeted tuberculin testing and treatment of latent tuberculosis infection. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. This is a Joint Statement of the American Thoracic Society (ATS) and the Centers for Disease Control and Prevention (CDC). This statement was endorsed by the Council of the Infectious Diseases Society of America. (IDSA), September 1999, and the sections of this statement. Am J Respir Crit Care Med 2000, 161(4 Pt 2):S221-247.
30. Wang L, Turner MO, Elwood RK, Schulzer M, FitzGerald JM. A meta-analysis of the effect of Bacille Calmette Guerin vaccination on tuberculin skin test measurements. Thorax 2002, 57(9):804-809. 10.1136/thorax.57.9.804, 1746436, 12200526.